In vitro Sensitivity Testing of Human Bladder Cancers and Cell Lines to TP-40, a Hybrid Protein with selective Targeting and Cytotoxicity

scientific article published in December 1993

In vitro Sensitivity Testing of Human Bladder Cancers and Cell Lines to TP-40, a Hybrid Protein with selective Targeting and Cytotoxicity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0022-5347(17)35944-X
P698PubMed publication ID8230543

P50authorDouglas YeeQ56985470
P2093author name stringD D von Hoff
M F Sarosdy
D H Hutzler
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)1950-1955
P577publication date1993-12-01
P1433published inJournal of UrologyQ15709979
P1476titleIn vitro sensitivity testing of human bladder cancers and cell lines to TP-40, a hybrid protein with selective targeting and cytotoxicity
P478volume150

Reverse relations

cites work (P2860)
Q36108466Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors
Q41442987Growth factors in bladder cancer
Q26751473Immunotoxin Therapies for the Treatment of Epidermal Growth Factor Receptor-Dependent Cancers
Q41022992Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges.
Q47231221The Use of Plant-Derived Ribosome Inactivating Proteins in Immunotoxin Development: Past, Present and Future Generations.
Q41229172Toxicity of ribosome-inactivating proteins-containing immunotoxins to a human bladder carcinoma cell line
Q39991480Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor

Search more.